532154 — Johnson Pharmacare Balance Sheet
0.000.00%
- IN₹495.00m
- IN₹500.91m
- 36
- 43
- 33
- 27
Annual balance sheet for Johnson Pharmacare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.33 | 0.406 | 0.018 | 0.014 | 0.144 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 53.7 | 41.4 | 0 | 0 | 143 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 56 | 41.8 | 0.018 | 0.014 | 156 |
Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 595 | 600 | 598 | 598 | 579 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.51 | 11.3 | 9.76 | 11.3 | 11.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 13.4 | 17.4 | 28.8 | 30.8 | 17.6 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 581 | 582 | 569 | 568 | 562 |
Total Liabilities & Shareholders' Equity | 595 | 600 | 598 | 598 | 579 |
Total Common Shares Outstanding |